CEACAM5 and colorectal carcinoma: A study recruited 83 patients with radically resected CRC and 16 patients with postoperative recurrence of CRC to undergo mSEPT9, fecal occult blood test (FOBT), CEA, and carbohydrate antigen 19–9 (CA19-9) testing, respectively.